A Multicenter, Double-blind, Double-dummy, Follow up Study Evaluating the Long-term Safety of Lacosamide in Comparison With Controlled-release Carbamazepine Used as Monotherapy in Subjects With Partial-onset or Generalized Tonic-clonic Seizures ≥16 Years of Age Coming From the SP0993 Study
Latest Information Update: 29 Nov 2019
At a glance
- Drugs Lacosamide (Primary) ; Carbamazepine
- Indications Partial epilepsies; Tonic-clonic epilepsy
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors UCB
- 12 Nov 2019 Results reporting primary safety outcomes from the double blind extension of the noninferiority trial (SP0994; NCT01465997) and post hoc analyses of pooled long term safety and efficacy data from (NCT01465997 and NCT01243177) published in the Epilepsia
- 04 Dec 2018 Results of post-hoc pooled analysis exploring long-term, clinically relevant outcomes during LCM and CBZ-CR monotherapy presented at the 72nd Annual Meeting of the American Epilepsy Society
- 11 Jan 2017 Status changed from active, no longer recruiting to completed.